Cargando…
Discovery of a novel DNA polymerase inhibitor and characterization of its antiproliferative properties
Chromosomal duplication is targeted by various chemotherapeutic agents for the treatment of cancer. However, there is no specific inhibitor of DNA polymerases that is viable for cancer management. Through structure-based in silico screening of the ZINC database, we identified a specific inhibitor of...
Autores principales: | Mishra, Bhanvi, Zhang, Sufang, Zhao, Hong, Darzynkiewicz, Zbigniew, Lee, Ernest Y.C., Lee, Marietta Y.W.T., Zhang, Zhongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422523/ https://www.ncbi.nlm.nih.gov/pubmed/30427259 http://dx.doi.org/10.1080/15384047.2018.1529126 |
Ejemplares similares
-
Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21(WAF1), Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry
por: Darzynkiewicz, Zbigniew, et al.
Publicado: (2015) -
Phosphorylation Alters the Properties of Pol η: Implications for Translesion Synthesis
por: Peddu, Chandana, et al.
Publicado: (2018) -
Regulation and Modulation of Human DNA Polymerase δ Activity and Function
por: Lee, Marietta Y. W. T., et al.
Publicado: (2017) -
PDIP46 (DNA polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ
por: Wang, Xiaoxiao, et al.
Publicado: (2016) -
DNA polymerase delta interacting protein 3 facilitates the activation and maintenance of DNA damage checkpoint in response to replication stress
por: Zhang, Sufang, et al.
Publicado: (2022)